FdaApplication
ANDA 214809
Identifiers
- fda_app_no: ANDA214809
Properties
| Property | Value |
|---|---|
| applicant_name | SHORLA PHARMA LTD |
| application_type | ANDA |
| approval_date | 2023-03-03 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NELARABINE | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
| NELARABINE | NELARABINE | 375MG/75ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
2 products